Earnings Call · Q3 FY2021·2021-11-03

Q3 21EPS +28.57%·Rev n/aQ2 21EPS +52.17%·Rev n/aQ1 21EPS +42.11%·Rev n/aQ4 20EPS -14.29%·Rev n/a⚠ consensus missing

10x Genomics, Inc. TXG

Eric Jaschke — Senior Director of Investor Relations and Strategic Finance

Serge Saxonov — Likely CEO or senior executive (based on leading the call and strategic remarks)

Unknown

Justin McAnear — Likely CFO or senior finance executive (based on financial discussion)

+11.2%1d on move date+10.8% vs SPY3d+6.3%5d+1.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TXG calls or request research access.

More TXG calls Browse calls Request research access